January 2021 877 Minor Hotels, a Bangkok-based international hotel owner, operator and investor, has signed a memorandum of understanding (MoU) with Funyard Hotels & Resorts (Member of Country Garden Core Business Alliance), which will see the expansion of its brands in China. The announcement comes at the time when the growth of China’s travel sector, already one of the world s most-watched inbound and outbound markets, is expected to accelerate following post-Covid-19 easing of movement restrictions for travellers. With demand for leisure and resort services shifting from overseas to domestic, optimism about China’s tourism and resort market is at all-time high. Minor Hotels’ globe-spanning network of hotels and resorts with a wellness and cultural element at their core ensures that the group is well poised for development in the China market where the appetite for leisure travel has never been greater. As one of the world’s top 20 hotel groups with 530 h
Pregnancy resource center expands to Paragould
Pregnancy resource center expands to Paragould By Miranda Reynolds | January 20, 2021 at 5:00 PM CST - Updated January 21 at 6:21 AM
PARAGOULD, Ark. (KAIT) - A pregnancy resource center in Jonesboro serves more than 500 clients a year and hope by expanding their services to Paragould, theyâll serve even more.
Options on Main offers the same, free services at their new center, Options in Paragould. Monday marked their first day to open.
âIt was very exciting. My girls that work here are very excited to be able to serve the community,â said Valerie Long, the executive director.
Government Policies to Ensure Better Proliferation for Automotive Retread Tires Market 2021 | Automotive Retread Tires Market to Expand with Assistance fro
Relief Therapeutics Holding AG: Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil
Relief ), a biopharmaceutical company with its lead compound RLF-100
TM (Aviptadil) in advanced clinical development to treat severe COVID-19 patients, and AdVita Lifescience GmbH (
AdVita ), a Germany-based, privately held pharmaceutical company developing effective products and strategies to improve the treatment and diagnosis of rare lung diseases, today announced the companies have signed a binding term sheet for Relief to acquire all shares of AdVita in exchange for EUR 25 million of Relief common shares, plus possible future contingent milestone payments of up to EUR 20 million. The closing of the transaction is subject to customary closing conditions as well as legal and securities regulatory approvals and is expected to occur in Q2 2021.